Research is at the center of all we do here at the SRF to find a cure for scleroderma. This is why, in 2018, we launched CONQUER (COllaborative, National QUality...
Read More
SAN FRANCISCO, October 3, 2023 — The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Boehringer Ingelheim, a leading research-driven biopharmaceutical company, will…
• Sanofi is inaugural partner • Initial focus on Interstitial Lung Disease Secondary to Scleroderma • SRF will submit and hold the IND as the trial Sponsor SAN FRANCISCO, August...
Read More
Today, the Scleroderma Research Foundation announces the launch of CONQUEST, a highly innovative platform clinical trial designed to rapidly advance promising treatments for scleroderma. Industry partner, Sanofi, will contribute the first experimental...
Read More
Dear Friends, Thank you for your dedication to the mission of the Scleroderma Research Foundation (SRF) where research is at the center of everything we do. Below you’ll find an update on...
Read More
Meet the Scleroderma Research Foundation’s newest staff member. Please join us in welcoming our new Development Database Manager, Ruben Cordoba. Ruben brings a strong analytical mindset and technical expertise to…
Amazon has announced that they are discontinuing AmazonSmile on February 20, 2023. To everyone who prioritized the SRF while you shopped, thank you. You’ve helped us accelerate the pace of…
As we start the new year, join us in welcoming the newest member of the team! Meet Kate Ceredona, our Director of Philanthropy. Kate is a development professional with over…
Today wouldn’t be complete without honoring the memory of another person—January 9th is also the birthday of Gay Saget, Bob’s sister who lost her battle with scleroderma in 1994. This video is...
Read More
The Scleroderma Research Foundation (SRF) reflects on one year after losing longtime supporter and board member, Bob Saget, and looks ahead to continuing his legacy in 2023. For more than…
